This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Lymphomatoid Granulomatosis
Information about Lymphomatoid Granulomatosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Lymphomatoid Granulomatosis
Most recent studies have shown that Lymphomatoid Granulomatosis shares some biological mechanisms with angioimmunoblastic-lymphadenopathy, b-cell-lymphomas, dermatologic-disorders, epstein-barr-virus-infections, granuloma, hodgkin-disease, lung-diseases, lung-neoplasms, lymphoma, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, nervousness, skin-neoplasms, t-cell-lymphoma, vasculitis, wegener-granulomatosis, yersinia-infections.
Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphomatoid Granulomatosis, and have been seen in publications frequently: Adhesion To Host, Cell Adhesion, Cell Differentiation, Cell Division, Cell Proliferation, Complement Activation, Granuloma Formation, Hypersensitivity, Immune Response, Inflammatory Response, Innate Immune Response, Localization, Locomotion, Mating, Pathogenesis, Phagocytosis, Regeneration, Secretion, Transport, Virulence
Quite a number of genes have been found to play important roles in Lymphomatoid Granulomatosis, such as ACE, CD4, CD8A, CFH, CREM, CTLA4, DDIT3, DDX6, GDI1, HLA-DQA1, IL2, INVS, KRT20, LMLN, MAP3K19, MID1, MS4A1, NHS, NOD2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.